ライフサイエンスコーパス: methylenedioxymethamphetamine

1 nts and stimulants, including "ecstasy" (3,4-methylenedioxymethamphetamine).

2 ful clinical activity (e.g. fenfluramine and methylenedioxymethamphetamine).

3 the locomotor enhancing effects of (+)-3, 4-methylenedioxymethamphetamine, a substituted amphetamine

4 paired the locomotor response of mice to 3,4-methylenedioxymethamphetamine (also known as "ecstasy")

5 MDMA (3,4-methylenedioxymethamphetamine, also popularly known as "

6 Moreover, the influences of methylenedioxymethamphetamine and cannabis co-use, cravi

7 c acid diethylamide), amphetamines, Ecstasy (methylenedioxymethamphetamine), and amyl/butyl nitrate w

8 res of heroin with other drugs (cocaine, 3,4-methylenedioxymethamphetamine, and morphine) were also t

9 e of several cations, such as clonidine, 3,4-methylenedioxymethamphetamine, and nicotine, which are k

10 roxycotinine, cotinine, benzoylecgonine, 3,4-methylenedioxymethamphetamine, and noroxycodone.

11 acid diethylamide," "LSD," "ayahuasca," "3,4-methylenedioxymethamphetamine," and "MDMA," in human sub

12 ridinium, phenylethylamine, amphetamine, and methylenedioxymethamphetamine are all more potent inhibi

13 proaches involve the use of ketamine and 3,4-methylenedioxymethamphetamine-assisted psychotherapy, wh

14 udy evaluated the efficacy and safety of 3,4-methylenedioxymethamphetamine-assisted therapy (MDMA-AT)

15 so, as observed ex vivo, incubation with 3,4-methylenedioxymethamphetamine, but not cocaine or methyl

16 (SERT) substrates like fenfluramine and 3,4-methylenedioxymethamphetamine cause long-term depletion

17 ly to rats and humans, the drug of abuse 3,4 methylenedioxymethamphetamine (ecstasy, MDMA) elicits hy

18 ver the next 21 years, except for use of 3,4-methylenedioxymethamphetamine ("ecstasy").

19 MDMA (+/- 3,4-methylenedioxymethamphetamine, 'ecstasy') is used recrea

20 Psychostimulants, such as cocaine and 3,4-methylenedioxymethamphetamine (i.e., "ecstasy"), also im

21 ic treatment with SERT substrates (5-HT, 3,4-methylenedioxymethamphetamine) increased both peak SERT

22 ntial for brain 5-HT homeostasis and for 3,4-methylenedioxymethamphetamine-induced hyperactivity.

23 MDMA (3,4-methylenedioxymethamphetamine) is a popular recreational

24 MDMA (3,4-methylenedioxymethamphetamine) is a psychoactive drug wi

25 n of substrates, including serotonin and 3,4-methylenedioxymethamphetamine, is unaffected.

26 Given the 3-8 hr half-life of methylenedioxymethamphetamine, it is likely that levels

27 mised controlled trials of psychedelics (3,4-methylenedioxymethamphetamine (known as MDMA), lysergic

28 to marked hallucinogenic effects, LSD exerts methylenedioxymethamphetamine-like empathogenic mood eff

29 demonstrates a possible association between methylenedioxymethamphetamine, marijuana, and catecholam

30 ion of links between seizures of illicit 3,4-methylenedioxymethamphetamine (MDMA or "ecstasy") has be

31 Both hallucinogens and 3,4-methylenedioxymethamphetamine (MDMA or "ecstasy") have d

32 The substituted amphetamine drugs, 3,4-methylenedioxymethamphetamine (MDMA or 'Ecstasy') and fe

33 3,4-methylenedioxymethamphetamine (MDMA or 'Ecstasy'), which

34 1.0 or 10.0 mg/kg) or an amphetamine analog, methylenedioxymethamphetamine (MDMA) (2.0, 5.0, or 10.0

35 etamine (METH) (2.5, 5.0 and 10.0 mg/kg) and methylenedioxymethamphetamine (MDMA) (5.0, 10.0 and 20.0

36 Abused by >1.2 million Americans, 3,4-methylenedioxymethamphetamine (MDMA) (commonly referred

37 Methylenedioxymethamphetamine (MDMA) and 5,7-dihydroxytr

38 bo-controlled trials using non-classical 3,4-methylenedioxymethamphetamine (MDMA) and classical psych

39 We discovered that ( )3,4-methylenedioxymethamphetamine (MDMA) and fenfluramine, t

40 ment, but substances including ketamine, 3,4-Methylenedioxymethamphetamine (MDMA) and ibogaine also h

41 tates after controlled administration of 3,4-methylenedioxymethamphetamine (MDMA) and intranasal oxyt

42 d by the structurally related compounds, 3,4-methylenedioxymethamphetamine (MDMA) and methamphetamine

43 These drugs are structurally similar to 3,4-methylenedioxymethamphetamine (MDMA) and share many of i

44 Rapidly acting therapeutics like 3,4-methylenedioxymethamphetamine (MDMA) are promising treat

45 Lysergic acid diethylamide (LSD) and 3,4-Methylenedioxymethamphetamine (MDMA) are widely used psy

46 Hyperthermia induced by 3,4-methylenedioxymethamphetamine (MDMA) can be life-threate

47 ation of METH or multiple administrations of methylenedioxymethamphetamine (MDMA) cause less of an ac

48 The acute administration of 3,4-methylenedioxymethamphetamine (MDMA) elevates extracellu

49 rit rigorous replication studies include 3,4-Methylenedioxymethamphetamine (MDMA) for post-traumatic

50 Recreational use of methylenedioxymethamphetamine (MDMA) has dramatically in

51 3,4-Methylenedioxymethamphetamine (MDMA) increases sociality

52 3,4-Methylenedioxymethamphetamine (MDMA) is a drug of abuse

53 The amphetamine derivative 3,4-methylenedioxymethamphetamine (MDMA) is a drug of abuse

54 The compound 3,4-methylenedioxymethamphetamine (MDMA) is a potent monoami

55 3,4-Methylenedioxymethamphetamine (MDMA) is a widely abused

56 3,4-methylenedioxymethamphetamine (MDMA) is an amphetamine d

57 3,4-Methylenedioxymethamphetamine (MDMA) is currently being

58 The psychoactive drug +/-3,4-methylenedioxymethamphetamine (MDMA) is increasingly use

59 Ingestion of 3, 4-methylenedioxymethamphetamine (MDMA) leads to heightened

60 as started to investigate the effects of 3,4-methylenedioxymethamphetamine (MDMA) on large-scale patt

61 estigate the effects of repeated exposure to methylenedioxymethamphetamine (MDMA) on responses of neu

62 Administration of 3,4-methylenedioxymethamphetamine (MDMA) or 3,4-methylenedio

63 The psychostimulant drug +/-3,4-methylenedioxymethamphetamine (MDMA) reportedly produces

64 sample the headspace over the following: 3,4-methylenedioxymethamphetamine (MDMA) tablets resulting i

65 ntemporary clinical trials of psychedelic or methylenedioxymethamphetamine (MDMA) therapy and corresp

66 We have previously shown that +/-3,4-methylenedioxymethamphetamine (MDMA) treatment from P11

67 (E) on the hyperactivity induced by (+)-3,4-methylenedioxymethamphetamine (MDMA) with E effects on c

68 (+/-)3,4-Methylenedioxymethamphetamine (MDMA), a widely used drug

69 The psychoactive stimulant 3, 4-methylenedioxymethamphetamine (MDMA), also known as "ecs

70 es to the more well-known drugs of abuse 3,4-methylenedioxymethamphetamine (MDMA), and methamphetamin

71 rmia induced by phenethylamines, such as 3,4-methylenedioxymethamphetamine (MDMA), can lead to life-t

72 "Ecstasy," or 3,4-methylenedioxymethamphetamine (MDMA), causes long-term i

73 N,N-Dimethyltryptamine (DMT), ayahuasca, 3,4-methylenedioxymethamphetamine (MDMA), modafinil, and met

74 timulants (amphetamine, methamphetamine, 3,4-methylenedioxymethamphetamine (MDMA), phentermine, and m

75 acy of lysergic acid diethylamide (LSD), 3,4-methylenedioxymethamphetamine (MDMA), psilocybin, and ay

76 nd 5-HT by methamphetamine (METH) and ( )3,4-methylenedioxymethamphetamine (MDMA), respectively, reca

77 3,4-Methylenedioxymethamphetamine (MDMA), the main psychoact

78 ansporters are altered following exposure to methylenedioxymethamphetamine (MDMA), which is commonly

79 al and a psychological approach, such as 3,4-methylenedioxymethamphetamine (MDMA)-assisted psychother

80 7014) to test the efficacy and safety of 3,4-methylenedioxymethamphetamine (MDMA)-assisted therapy fo

81 or bioenergetic stress may contribute to 3,4-methylenedioxymethamphetamine (MDMA)-induced 5-HT toxici

82 The specific mechanisms underlying (+)-3,4-methylenedioxymethamphetamine (MDMA)-induced damage to 5

83 of a common binding pocket for 5-HT and 3,4-methylenedioxymethamphetamine (MDMA).

84 scovered that the amphetamine derivative 3,4-methylenedioxymethamphetamine (MDMA, "Ecstasy") and its

85 Among young adults, 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy") is a pop

86 (+/-)3,4-methylenedioxymethamphetamine (MDMA, "Ecstasy") is a pop

87 The recreational drug (+/-)3,4-methylenedioxymethamphetamine (MDMA, "Ecstasy") is a pot

88 user reports of subjective similarity to 3,4-methylenedioxymethamphetamine (MDMA, "Ecstasy") prompted

89 otentially fatal manifestation of severe 3,4-methylenedioxymethamphetamine (MDMA, Ecstasy) intoxicati

90 3,4-methylenedioxymethamphetamine (MDMA, ecstasy) is a popul

91 Methylenedioxymethamphetamine (MDMA, Ecstasy) is a power

92 plored the association between abuse of 3, 4-methylenedioxymethamphetamine (MDMA, or "Ecstasy") and h

93 that the popular recreational drug (+/-)3,4-methylenedioxymethamphetamine (MDMA, or "ecstasy") is a

94 3,4-Methylenedioxymethamphetamine (MDMA, or ecstasy) is a re

95 Methylenedioxymethamphetamine (MDMA; "Ecstasy") is a pop

96 nfluramine (an appetite suppressant) and 3,4-methylenedioxymethamphetamine (MDMA; "Ecstasy") revealed

97 e discovery that amphetamines, including 3,4-methylenedioxymethamphetamine (MDMA; "ecstasy"), are pot

98 antic and topological structure after +/-3,4-methylenedioxymethamphetamine (MDMA; 'ecstasy') and meth

99 Use of 3,4-methylenedioxymethamphetamine (MDMA; ecstasy) has increa

100 TH], (+)-amphetamine [(+)-AMP], or (+/-)-3,4-methylenedioxymethamphetamine ((+/-)-MDMA, commonly call

101 In mice, the recreational drug (+/-)3,4-methylenedioxymethamphetamine [MDMA ("ecstasy")] produce

102 baboon with reduced SERT density ((+/-)-3,4-methylenedioxymethamphetamine [MDMA] lesion), and a babo

103 The most common form of ecstasy (3,4-methylenedioxymethamphetamine [MDMA]), is an amphetamine

104 recently, the recreational drug ecstasy (3,4 methylenedioxymethamphetamine; MDMA) have been implicate

105 hetamine-like dopamine releasers such as 3,4-methylenedioxymethamphetamine, methamphetamine, amphetam

106 d thermogenic response to the drug MDMA (3,4-methylenedioxymethamphetamine, nicknamed 'ecstasy') and

107 n psychotropics, psychedelics, ketamine, 3,4-methylenedioxymethamphetamine (or ecstasy), stimulants,

108 osure to cocaine, amphetamine, MDMA [(+)-3,4-methylenedioxymethamphetamine], or nicotine in rats.

109 To the extent that use of ketamine and 3,4-methylenedioxymethamphetamine promotes symptom improveme

110 iations that naturalistic lifetime MDMA (3,4-Methylenedioxymethamphetamine) use and psilocybin use sh